Prognostic Factors of Survival for Patients with Stage Ⅲ and Stage Ⅳ Epithelial Ovarian Cancer

Rong-yu ZANG,Z ZHANG,Zi-ting LI,Shu-mo CAI,Jie CHEN,Mei-qin TANG

DOI: https://doi.org/10.3969/j.issn.1672-8467.2001.01.013

2001-01-01

Abstract:Purpose To investigate the prognostic factors of survival in patients with advanced epithelialovarian cancer (EOC). Methods 265 and 71 patients with stage Ⅲ and stage Ⅳ EOC respectivelycomputerized statistical analyses, using SPSS software, were performed to estimate the survival. The survivalrate was calculated by life table, with survival difference tested by log-rank test. Cox stepwise regressionmodel was used to detect prognostic factors of survival. Results 120 (45.28 % ) stage Ⅲl patients wereoptimally cytoreduced during primary surger, with an estimated five-year survival of 38.56 %. Residualdisease was also a significant prognostic determinant of survival in patients with stage Ⅳ EOC, mainly inthose with malignant pleural effusion and surpraclavicular lymphadenopathy. Cox stepwise regression analysisrevealed that residual disease (P = 0. 000 0), the muscle of uteri corpus or cervix involved by the tumor(P = 0. 002 9), refractory ascites ( P = 0. 000 0), adjuvant chemotherapy, and cell types ( P = 0. 003 8 )were identified to be independent prognostic factors of survival for stage Ⅲ EOC patients. NeoadjuvaNtchemotherapy was associated with progression-free survival. Acites was also an independent prognosticfactors of survival for stage Ⅳ disease (P = 0. 004 3). Conclusions Residual disease, refractory aseit es,types of histology, and adjuvant chemotherapy were prognostic factors of survival for patients with advancedEOC. Besides residual disease, ascites was an important prognostic factors of survival of stage Ⅳ disease.